跳至主要内容
临床试验/NCT06529861
NCT06529861尚未招募不适用

Identification of Mechanisms Behind Microvascular Dysfunction in Ischemia With No Obstructive Coronary Artery Disease

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Vascular function in response to acetylcholine stress

研究概览

简要总结

The purpose of the study is to identify the causes of chest pain in patients experiencing chest pain with no signs of narrowing in the coronary arteries of the heart.

详细描述

A significant number of patients with ischemic heart disease do not exhibit coronary obstruction, leading to their symptoms being attributed to coronary microvascular dysfunction, a condition known as ischemia with no obstructive coronary artery disease (INOCA). Despite a considerable patient population affected by INOCA, the specific mechanisms underlying this microvascular dysfunction are not fully understood, often resulting in a lack of targeted treatment. There is evidence to suggest that exercise capacity is linked to coronary microvascular function, an area yet to be explored.

This study aims to identify mechanisms underlying Coronary microvascular dysfunction (CMD) in angina and to assess whether exercise training can improve the condition. In study part I 30 patients with impaired coronary microvascular function and 30 asymptomatic controls will be studied to identify vascular and related molecular mechanisms underlying INOCA by investigating microvascular function in the heart and in cutaneous tissue, skeletal muscle, and adipose tissue.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Only for angina patients: Have CMD, defined as myocardial bloodflow re-serve (MBFR) < 2.5 or hyperemic myocardial blood flow (hMBF) < 2.3ml/g/min

排除标准

  • Females of childbearing potential (defined as a premeno-pausal female capable of becoming pregnant). The female patient must either be postmenopausal, defined as amen-orrhea for at least 1 year, or surgically sterile
  • Heart failure, defined as left ventricular ejection fraction of less than 40%
  • Uncontrolled hypertension defined as blood pressure above target 140/90 for all
  • Co-morbidity resulting in <1 year expected survival
  • Considered by the investigator, for any reason, to be an unsuitable candidate for the study.
  • Unable or unwilling to exercise, e.g. due to arthritis or injury*
  • Already are regularly physically active and/or have a maximal oxygen uptake >45 ml/kg/min
  • The subject has a known allergy to either: norepinephrine, adenosine, ketorolac, and or ascorbic acid (vitamin C).

结局指标

主要结局

Vascular function in response to acetylcholine stress

时间窗: Baseline only

Vascular conductance measured by ultrasound doppler during infusion of acetylcholine

次要结局

  • Vascular function in response to acetylcholine adenosine stress(Baseline only)
  • Plasma Levels of Inflammatory Markers(Baseline only)
  • Arterial Blood Pressure(Baseline only)
  • Myocardial Blood flow reserve(Baseline only)
  • Changes in isolated small artery reactivity assessed with myography(Baseline only)
  • Plasma Lipids(Baseline only)
  • Plasma HbA1c(Baseline only)
  • Plasma Levels of Markers Related to Vascular Function(Baseline only)
  • Cardiac Function(Baseline only)
  • Arterial Compliance(Baseline only)
  • Skeletal Muscle Microvascular Function(Baseline only)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva Prescott

MD Clinical Professor

Bispebjerg Hospital

研究点 (1)

Loading locations...

相似试验

Mechanisms Behind Microvascular Dysfunction in INOCA | 临床试验